Literature DB >> 21255577

Control of onchocerciasis in Africa: threshold shifts, breakpoints and rules for elimination.

Hans P Duerr1, Günter Raddatz, Martin Eichner.   

Abstract

Control of onchocerciasis in Africa is currently based on annual community-directed treatment with ivermectin (CDTI) which has been assumed to be not efficient enough to bring about elimination. However, elimination has recently been reported to have been achieved by CDTI alone in villages of Senegal and Mali, reviving debate on the eradicability of onchocerciasis in Africa. We investigate the eradicability of onchocerciasis by examining threshold shifts and breakpoints predicted by a stochastic transmission model that has been fitted extensively to data. We show that elimination based on CDTI relies on shifting the threshold biting rate to a level that is higher than the annual biting rate. Breakpoints become relevant in the context of when to stop CDTI. In order for the model to predict a good chance for CDTI to eliminate onchocerciasis, facilitating factors such as the macrofilaricidal effect of ivermectin must be assumed. A chart predicting the minimum efficacy of CDTI required for elimination, dependent on the annual biting rate, is provided. Generalisable recommendations into strategies for the elimination of onchocerciasis are derived, particularly referring to the roles of vectors, the residual infection rate under control, and a low-spreader problem originating from patients with low parasite burdens.
Copyright © 2011 Australian Society for Parasitology Inc. Published by Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21255577     DOI: 10.1016/j.ijpara.2010.12.009

Source DB:  PubMed          Journal:  Int J Parasitol        ISSN: 0020-7519            Impact factor:   3.981


  37 in total

1.  Impact of long-term treatment of onchocerciasis with ivermectin in Kaduna State, Nigeria: first evidence of the potential for elimination in the operational area of the African Programme for Onchocerciasis Control.

Authors:  Afework Hailemariam Tekle; Elizabeth Elhassan; Sunday Isiyaku; Uche V Amazigo; Simon Bush; Mounkaila Noma; Simon Cousens; Adenike Abiose; Jan H Remme
Journal:  Parasit Vectors       Date:  2012-02-07       Impact factor: 3.876

2.  The impact of mass drug administration expansion to low onchocerciasis prevalence settings in case of connected villages.

Authors:  Anneke S de Vos; Wilma A Stolk; Luc E Coffeng; Sake J de Vlas
Journal:  PLoS Negl Trop Dis       Date:  2021-05-12

3.  Feasibility of Onchocerciasis Elimination Using a "Test-and-not-treat" Strategy in Loa loa Co-endemic Areas.

Authors:  David J Blok; Joseph Kamgno; Sebastien D Pion; Hugues C Nana-Djeunga; Yannick Niamsi-Emalio; Cedric B Chesnais; Charles D Mackenzie; Amy D Klion; Daniel A Fletcher; Thomas B Nutman; Sake J de Vlas; Michel Boussinesq; Wilma A Stolk
Journal:  Clin Infect Dis       Date:  2021-06-15       Impact factor: 9.079

4.  Proof-of-principle of onchocerciasis elimination with ivermectin treatment in endemic foci in Africa: final results of a study in Mali and Senegal.

Authors:  Mamadou O Traore; Moussa D Sarr; Alioune Badji; Yiriba Bissan; Lamine Diawara; Konimba Doumbia; Soula F Goita; Lassana Konate; Kalifa Mounkoro; Amadou F Seck; Laurent Toe; Seyni Toure; Jan H F Remme
Journal:  PLoS Negl Trop Dis       Date:  2012-09-13

Review 5.  A research agenda for helminth diseases of humans: towards control and elimination.

Authors:  Boakye A Boatin; María-Gloria Basáñez; Roger K Prichard; Kwablah Awadzi; Rashida M Barakat; Héctor H García; Andrea Gazzinelli; Warwick N Grant; James S McCarthy; Eliézer K N'Goran; Mike Y Osei-Atweneboana; Banchob Sripa; Guo-Jing Yang; Sara Lustigman
Journal:  PLoS Negl Trop Dis       Date:  2012-04-24

Review 6.  A research agenda for helminth diseases of humans: modelling for control and elimination.

Authors:  María-Gloria Basáñez; James S McCarthy; Michael D French; Guo-Jing Yang; Martin Walker; Manoj Gambhir; Roger K Prichard; Thomas S Churcher
Journal:  PLoS Negl Trop Dis       Date:  2012-04-24

7.  The potential impact of moxidectin on onchocerciasis elimination in Africa: an economic evaluation based on the Phase II clinical trial data.

Authors:  Hugo C Turner; Martin Walker; Simon K Attah; Nicholas O Opoku; Kwablah Awadzi; Annette C Kuesel; María-Gloria Basáñez
Journal:  Parasit Vectors       Date:  2015-03-19       Impact factor: 3.876

8.  Uncertainty surrounding projections of the long-term impact of ivermectin treatment on human onchocerciasis.

Authors:  Hugo C Turner; Thomas S Churcher; Martin Walker; Mike Y Osei-Atweneboana; Roger K Prichard; María-Gloria Basáñez
Journal:  PLoS Negl Trop Dis       Date:  2013-04-25

9.  Dynamics of Onchocerca volvulus microfilarial densities after ivermectin treatment in an ivermectin-naïve and a multiply treated population from Cameroon.

Authors:  Sébastien D S Pion; Hugues C Nana-Djeunga; Joseph Kamgno; Nicholas Tendongfor; Samuel Wanji; Flobert Njiokou; Roger K Prichard; Michel Boussinesq
Journal:  PLoS Negl Trop Dis       Date:  2013-02-28

10.  Onchocerciasis: the pre-control association between prevalence of palpable nodules and skin microfilariae.

Authors:  Luc E Coffeng; Sébastien D S Pion; Simon O'Hanlon; Simon Cousens; Adenike O Abiose; Peter U Fischer; Jan H F Remme; K Yankum Dadzie; Michele E Murdoch; Sake J de Vlas; María-Gloria Basáñez; Wilma A Stolk; Michel Boussinesq
Journal:  PLoS Negl Trop Dis       Date:  2013-04-11
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.